Yasuyoshi Miyata
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 12
- Urology top 2%
- Urinary Bladder and Prostate Research 14
- Oncology top 5%
- Molecular Biology top 5%
- Angiogenesis and VEGF in Cancer 23
-
- Renal cell carcinoma treatment 23
- Prostate Cancer Treatment and Research 14
-
- Bladder and Urothelial Cancer Treatments 26
- Urinary and Genital Oncology Studies 13
-
- Inflammatory mediators and NSAID effects 12
- Co-authors
- Hiroshi KanetakeShigeru KandaHideki SakaiKojiro OhbaTomohiro MatsuoTomayoshi HayashiKensuke MitsunariYasushi Mochizuki
- Cited by
- Cancer ResearchUrologyOncology
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Yasuyoshi Miyata
171 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 608
- Urology 213
- Oncology 641
- Molecular Biology 1.5k
- Pulmonary and Respiratory Medicine 570
Countries citing papers authored by Yasuyoshi Miyata
This map shows the geographic impact of Yasuyoshi Miyata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuyoshi Miyata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuyoshi Miyata more than expected).
Fields of papers citing papers by Yasuyoshi Miyata
This network shows the impact of papers produced by Yasuyoshi Miyata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuyoshi Miyata. The network helps show where Yasuyoshi Miyata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yasuyoshi Miyata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 5 | |
| 4 | 2021 | 1 | |
| 5 | 2019 | 92 | |
| 6 | 2019 | 5 | |
| 7 | 2019 | 14 | |
| 8 | 2018 | 14 | |
| 9 | 2017 | 35 | |
| 10 | 2017 | 2 | |
| 11 | 2017 | 7 | |
| 12 | 2014 | 12 | |
| 13 | 2013 | 21 | |
| 14 | 2008 | 9 | |
| 15 | 2007 | 6 | |
| 16 | 2007 | 33 | |
| 17 | Calreticulin down-regulates E-cadherin gene expression via Slug in a Ca2+-dependent manner | 2006 | 1 |
| 18 | 2006 | 9 | |
| 19 | 2004 | 49 | |
| 20 | 2003 | 144 |
About Yasuyoshi Miyata
Yasuyoshi Miyata is a scholar working on Urology, Applied Microbiology and Biotechnology, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 174 papers that have together received 3.3k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (26 papers), Renal cell carcinoma treatment (23 papers), Angiogenesis and VEGF in Cancer (23 papers), Urinary Bladder and Prostate Research (14 papers), Prostate Cancer Treatment and Research (14 papers), Urinary and Genital Oncology Studies (13 papers), Protease and Inhibitor Mechanisms (12 papers) and Inflammatory mediators and NSAID effects (12 papers). The work is most often cited by research in Cancer Research (608 citations), Urology (213 citations), Oncology (641 citations), Molecular Biology (1.5k citations) and Pulmonary and Respiratory Medicine (570 citations). Yasuyoshi Miyata has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Hiroshi Kanetake, Shigeru Kanda, Hideki Sakai, Kojiro Ohba, Tomohiro Matsuo, Hideki Sakai, Tomayoshi Hayashi, Kensuke Mitsunari, Yasushi Mochizuki and Koichiro Nomata. Their work appears in journals such as Anticancer Research, Urology, The Journal of Urology, International Journal of Urology and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.